Table 2. Treatment and dose-limiting toxicities for each dose level (all cycles).
| Tremelimumab, mg kg−1 | PF-3512676, mg kg−1 | Patients, n | Dose-limiting toxicities, n |
|---|---|---|---|
| 6 |
0.05 |
3 |
0 |
| 10 |
0.05 |
6 |
1 |
| 15 |
0.05 |
6 |
2 |
| 10 |
0.10 |
3 |
1 |
| 10 | 0.15 | 3 | 2 |